Hideyuki Inoue

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Impact of Tirzepatide on FIB-4 in Patients with Type 2 Diabetes: A Comparison between GLP-1RA-naïve and GLP-1RA Switch Initiation in a Retrospective Cohort.

Impact of Tirzepatide on FIB-4 in Patients with Type 2 Diabetes: A Comparison between GLP-1RA-naïve and GLP-1RA Switch Initiation in a Retrospective Cohort.

Journal: Internal medicine (Tokyo, Japan)

Published: April 29, 2026

Fibrosis-4 (FIB-4) Index Is Associated With Skeletal Muscle Mass in Japanese Patients With Type 2 Diabetes: A Single-Center Retrospective Cross-Sectional Study.

Fibrosis-4 (FIB-4) Index Is Associated With Skeletal Muscle Mass in Japanese Patients With Type 2 Diabetes: A Single-Center Retrospective Cross-Sectional Study.

Journal: Cureus

Published: April 27, 2026

Diabetic peripheral neuropathy as an independent predictor of renal function decline in type 2 diabetes: a propensity score-matched retrospective cohort study using DPN-Check®.

Diabetic peripheral neuropathy as an independent predictor of renal function decline in type 2 diabetes: a propensity score-matched retrospective cohort study using DPN-Check®.

Journal: Clinical and experimental nephrology

Published: March 05, 2026

Association of urinary post-translationally modified fetuin-A fragments with diabetic kidney disease risk stratification in Japanese patients with type 2 diabetes.

Association of urinary post-translationally modified fetuin-A fragments with diabetic kidney disease risk stratification in Japanese patients with type 2 diabetes.

Journal: PloS one

Published: September 26, 2025

Prevalence and Associated Factors of Overactive Bladder in Japanese Patients With Type 2 Diabetes.

Prevalence and Associated Factors of Overactive Bladder in Japanese Patients With Type 2 Diabetes.

Journal: Geriatrics & gerontology international

Published: July 25, 2025

Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes.

Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes.

Journal: Expert opinion on pharmacotherapy

Published: March 28, 2025

Relationship between changes in uric acid levels and renal function during 12 months of treatment with luseogliflozin.

Relationship between changes in uric acid levels and renal function during 12 months of treatment with luseogliflozin.

Journal: Diabetology international

Published: March 28, 2025

Phase Angle Evaluated by a Bioimpedance Analysis Is Closely Related to Diabetic Nephropathy and Peripheral Neuropathy in Patients with Type 2 Diabetes.

Phase Angle Evaluated by a Bioimpedance Analysis Is Closely Related to Diabetic Nephropathy and Peripheral Neuropathy in Patients with Type 2 Diabetes.

Journal: JMA journal

Published: February 12, 2025

Deterioration of the Defecation Status after Hospitalization in Patients with Type 2 Diabetes Is Associated with Albuminuria Rather Than Diabetic Neuropathy.

Deterioration of the Defecation Status after Hospitalization in Patients with Type 2 Diabetes Is Associated with Albuminuria Rather Than Diabetic Neuropathy.

Journal: Internal medicine (Tokyo, Japan)

Published: November 27, 2024

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes.

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes.

Journal: Journal of diabetes investigation

Published: November 13, 2024

Effect of Baseline Values of Renal Prognosis-related Factors on Their Changes after Initiating Tofogliflozin Treatment: A Retrospective Study in Japanese Patients with Type 2 Diabetes and Renal Impairment.

Effect of Baseline Values of Renal Prognosis-related Factors on Their Changes after Initiating Tofogliflozin Treatment: A Retrospective Study in Japanese Patients with Type 2 Diabetes and Renal Impairment.

Journal: JMA journal

Published: June 19, 2024

A Case of Diabetic Chorea Secondary to Appetite Loss Due to COVID-19 Vaccination.

A Case of Diabetic Chorea Secondary to Appetite Loss Due to COVID-19 Vaccination.

Journal: Cureus

Published: November 20, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026